BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19426690)

  • 21. Expression and coupling of neurokinin receptor subtypes to inositol phosphate and calcium signaling pathways in human airway smooth muscle cells.
    Mizuta K; Gallos G; Zhu D; Mizuta F; Goubaeva F; Xu D; Panettieri RA; Yang J; Emala CW
    Am J Physiol Lung Cell Mol Physiol; 2008 Mar; 294(3):L523-34. PubMed ID: 18203813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating the effect of bilateral amygdala lesions on fear conditioning and social interaction in the male Mongolian gerbil.
    Woolley ML; Haman M; Higgins GA; Ballard TM
    Brain Res; 2006 Mar; 1078(1):151-8. PubMed ID: 16494851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two major groups of rat NKR-P1 receptors can be distinguished based on chromosomal localization, phylogenetic analysis and Clr ligand binding.
    Kveberg L; Dai KZ; Westgaard IH; Daws MR; Fossum S; Naper C; Vaage JT
    Eur J Immunol; 2009 Feb; 39(2):541-51. PubMed ID: 19130483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptors and antagonists for substance P and related peptides.
    Regoli D; Boudon A; Fauchére JL
    Pharmacol Rev; 1994 Dec; 46(4):551-99. PubMed ID: 7534932
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of a novel transmembrane domain involved in the negative modulation of mGluR1 using a newly discovered allosteric mGluR1 antagonist, 3-cyclohexyl-5-fluoro-6-methyl-7-(2-morpholin-4-ylethoxy)-4H-chromen-4-one.
    Fukuda J; Suzuki G; Kimura T; Nagatomi Y; Ito S; Kawamoto H; Ozaki S; Ohta H
    Neuropharmacology; 2009 Sep; 57(4):438-45. PubMed ID: 19559036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist.
    Gerspacher M; Lewis C; Ball HA; Howes C; Subramanian N; Ryffel K; Fozard JR
    J Med Chem; 2003 Jul; 46(16):3508-13. PubMed ID: 12877589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity.
    Aharony D; Buckner CK; Ellis JL; Ghanekar SV; Graham A; Kays JS; Little J; Meeker S; Miller SC; Undem BJ
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1216-21. PubMed ID: 7562491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
    Juszczak M
    Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist.
    Megens AA; Ashton D; Vermeire JC; Vermote PC; Hens KA; Hillen LC; Fransen JF; Mahieu M; Heylen L; Leysen JE; Jurzak MR; Janssens F
    J Pharmacol Exp Ther; 2002 Aug; 302(2):696-709. PubMed ID: 12130734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies.
    Juszczak M; Boczek-Leszczyk E; Stempniak B
    J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists.
    Misu R; Noguchi T; Ohno H; Oishi S; Fujii N
    Bioorg Med Chem; 2013 Apr; 21(8):2413-2417. PubMed ID: 23473945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.
    Blaney FE; Raveglia LF; Artico M; Cavagnera S; Dartois C; Farina C; Grugni M; Gagliardi S; Luttmann MA; Martinelli M; Nadler GM; Parini C; Petrillo P; Sarau HM; Scheideler MA; Hay DW; Giardina GA
    J Med Chem; 2001 May; 44(11):1675-89. PubMed ID: 11356103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tachykinin receptor and neutral endopeptidase gene expression in the rat uterus: characterization and regulation in response to ovarian steroid treatment.
    Pinto FM; Armesto CP; Magraner J; Trujillo M; Martín JD; Candenas ML
    Endocrinology; 1999 Jun; 140(6):2526-32. PubMed ID: 10342838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation.
    Liu C; Wilson SJ; Kuei C; Lovenberg TW
    J Pharmacol Exp Ther; 2001 Oct; 299(1):121-30. PubMed ID: 11561071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a dipeptide chemical library in the development of non-peptide tachykinin NK3 receptor selective antagonists.
    Boden P; Eden JM; Hodgson J; Horwell DC; Hughes J; McKnight AT; Lewthwaite RA; Pritchard MC; Raphy J; Meecham K; Ratcliffe GS; Suman-Chauhan N; Woodruff GN
    J Med Chem; 1996 Apr; 39(8):1664-75. PubMed ID: 8648606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
    Juszczak M; Boczek-Leszczyk E
    J Physiol Pharmacol; 2008 Sep; 59(3):553-62. PubMed ID: 18953097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptor.
    Geldenhuys WJ; Kuzenko SR; Simmons MA
    J Med Chem; 2010 Nov; 53(22):8080-8. PubMed ID: 21047106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ischemia on tachykinin-containing nerves and neurokinin receptors in the rabbit bladder.
    Azadzoi KM; Radisavljevic ZM; Siroky MB
    Urology; 2008 May; 71(5):979-83. PubMed ID: 18314167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization and function of NK(3) subtype tachykinin receptors of layer V pyramidal neurons of the guinea-pig medial prefrontal cortex.
    Simmons MA; Sobotka-Briner CD; Medd AM
    Neuroscience; 2008 Oct; 156(4):987-94. PubMed ID: 18801417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.